Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome. - Ekins S; Gerlach J; Zorn KM; Antonio BM; Lin Z; Gerlach A (Pharmaceutical research, 2019)